Cytogenetics in the genomic era.


Journal

Best practice & research. Clinical haematology
ISSN: 1532-1924
Titre abrégé: Best Pract Res Clin Haematol
Pays: Netherlands
ID NLM: 101120659

Informations de publication

Date de publication:
09 2020
Historique:
received: 24 02 2020
revised: 30 04 2020
accepted: 27 05 2020
entrez: 11 10 2020
pubmed: 12 10 2020
medline: 8 10 2021
Statut: ppublish

Résumé

Haematological neoplasms are characterised by the presence of recurrent chromosomal abnormalities, making cytogenetics essential for establishing the diagnosis and prognosis. Chromosome banding analysis is mandatory for chronic myeloid leukaemia, neoplasms with eosinophilia, myelodysplastic syndromes and acute leukaemias. In contrast, in other myeloid neoplasms, chronic lymphocytic leukaemia, non-Hodgkin lymphoma and multiple myeloma, the study must be complemented with fluorescence in situ hybridization and/or microarrays, which can overcome some of the shortcomings of banding analysis to identify potential cryptic alterations or reciprocal translocations. In the genomic era, novel technologies such as next generation sequencing are now being used in clinical routine analysis, since they offer the possibility of studying mutations and copy number alterations in a single study at a higher resolution and/or sensitivity. However, they require highly qualified staff and further standardisation, especially regarding data analysis, thereby limiting their current applicability.

Identifiants

pubmed: 33038985
pii: S1521-6926(20)30057-8
doi: 10.1016/j.beha.2020.101196
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101196

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Isabel Granada (I)

Hematology Laboratory Service, ICO-Hospital GermansTrias i Pujol, Carretera de Canyet, s/n, 08916, Badalona, Barcelona, Spain. Electronic address: igranada@iconcologia.net.

Laura Palomo (L)

MDS Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital GermansTrias i Pujol, Universitat Autònoma de Barcelona, Carretera de Can Ruti, Camí de les escoles, s/n, 08916, Badalona, Barcelona, Spain. Electronic address: lpalomo@carrerasresearch.org.

Neus Ruiz-Xivillé (N)

Hematology Laboratory Service, ICO-Hospital GermansTrias i Pujol, Carretera de Canyet, s/n, 08916, Badalona, Barcelona, Spain. Electronic address: nruiz@iconcologia.net.

Mar Mallo (M)

MDS Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital GermansTrias i Pujol, Universitat Autònoma de Barcelona, Carretera de Can Ruti, Camí de les escoles, s/n, 08916, Badalona, Barcelona, Spain. Electronic address: mmallo@carrerasresearch.org.

Francesc Solé (F)

Hematology Laboratory Service, ICO-Hospital GermansTrias i Pujol, Carretera de Canyet, s/n, 08916, Badalona, Barcelona, Spain; MDS Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital GermansTrias i Pujol, Universitat Autònoma de Barcelona, Carretera de Can Ruti, Camí de les escoles, s/n, 08916, Badalona, Barcelona, Spain. Electronic address: fsole@carrerasresearch.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH